Sanofi

Sanofi, Regeneron launch trials of arthritis drug Kevzara for COVID-19

The interleukin-6 inhibitor will be evaluated in critically ill patients. Regeneron and Sanofi are the latest in a string of drugmakers looking to develop new, or evaluate existing, therapeutics for ... To initiate this trial quickly, so that the results

Lilly and AbCellera partner on antibody therapies for COVID-19

A host of companies are also looking to develop therapeutics or vaccine for use against the virus, including Takeda, Gilead, Sanofi, GlaxoSmithKline and Moderna.

Lilly joins new Medicare scheme to reduce insulin prices

Lilly, along with other insulin manufacturers including Sanofi and Novo Nordisk, have been cutting the price of their products in response to increasing public pressure over the increase in costs for

Gates Foundation, Wellcome launch fast-track COVID-19 therapy fund

A number of vaccines for the novel coronavirus are already being developed by a range of drugmakers, including Sanofi, GSK and Moderna. ... Sanofi’s work on a potential vaccine has also been fast-tracked by the US Department of Health and Human

BMS, AbbVie’s Empliciti flunks trial in first-line multiple myeloma

Earlier this month, Sanofi claimed FDA approval for Sarclisa (isatuximab) in relapsed/refractory myeloma, while J&J and Genmab already have a successor to Darzalex in late-stage development – Hexabody-CD38 –

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]